Literature DB >> 11666224

Kinetics and Mechanism of the Reaction between Serum Albumin and Auranofin (and Its Isopropyl Analogue) in Vitro.

Jacqueline R. Roberts1, Jun Xiao, Brian Schliesman, David J. Parsons, C. Frank Shaw.   

Abstract

The first detailed kinetic analysis and mechanistic interpretation of the reactions between serum albumin and the second-generation gold drug Auranofin [Et(3)PAuSATg = (triethylphosphine)(2,3,4,6-tetra-O-acetyl-1-beta-D-glucopyranosato-S-) gold(I)] and its triisopropylphosphine analogue, iPr(3)PAuSATg, in vitro are reported. The reactions were investigated using Penefsky spun columns and NMR saturation transfer methods. Under the Penefsky chromatography conditions with 0.4-0.6 mM albumin and a wide range of Et(3)PAuSATg concentrations, the reaction is biphasic. The fast phase is apparently first order in albumin with a rate constant [k(1) = 3.4 +/- 0.3 x 10(-)(2) s(-)(1)] that decreases slightly in magnitude and becomes intermediate in order at low gold concentrations, [Et(3)PAuSATg] < [AlbSH]; it accounts for approximately 95% of the Au(I) that binds. A minor, slower step [k(2) = 2.3 +/- 0.3 x 10(-)(3) s(-)(1)), which accounts for only 5% of the reaction, is also first order with respect to albumin, and zero order with respect to auranofin. For iPr(3)PAuSATg, only the first step was observed, k(1) = (1.4 +/- 0.1) x 10(-)(2) s(-)(1), and is first order in albumin and independent of the iPr(3)PAuSATg concentration. (31)P-NMR saturation transfer experiments utilizing iPr(3)PAuSATg, under equilibrium conditions, yielded second-order rate constants for both the forward (1.2 x 10(2) M(-)(1) s(-)(1)) and the reverse (3.9 x 10(1) M(-)(1) s(-)(1)) directions. A multistep mechanism involving a conformationally altered albumin species was developed. Albumin domain IA opens with concomitant Cys-34 rearrangement, allowing facile gold binding and exchange, and then closes. In conjunction with the steady-state approximation, this mechanism accounts for the different reaction orders observed under the two set of conditions. The rate-determining conformational change of albumin governs the reaction as monitored by the Penefsky columns. Rapid second order exchange of R(3)PAuSATg at the exposed Cys-34 residue is observed under the NMR conditions. The mechanism predicts that under physiological conditions where [Et(3)PAuSATg] is 10-25 &amp;mgr;M, the reaction will be second order and rapid with a rate constant of 8 +/- 2 x 10(2) M(-)(1) s(-)(1). The Penefsky spun columns revealed a previously unreported and novel binding mechanism, association of auranofin in the pocket of albumin-disulfide species, which was confirmed by Hummel-Dreyer gel chromatographic techniques under equilibrium conditions. This albumin-auranofin complex (AlbSSR-Et(3)PAuSATg) is weakly bound and readily dissociates during conventional gel exclusion chromatography.

Entities:  

Year:  1996        PMID: 11666224     DOI: 10.1021/ic9414280

Source DB:  PubMed          Journal:  Inorg Chem        ISSN: 0020-1669            Impact factor:   5.165


  9 in total

1.  Gold-containing indoles as anticancer agents that potentiate the cytotoxic effects of ionizing radiation.

Authors:  Sandra Craig; Lei Gao; Irene Lee; Thomas Gray; Anthony J Berdis
Journal:  J Med Chem       Date:  2012-02-15       Impact factor: 7.446

Review 2.  Physiological and pathological changes in the redox state of human serum albumin critically influence its binding properties.

Authors:  K Oettl; R E Stauber
Journal:  Br J Pharmacol       Date:  2007-04-30       Impact factor: 8.739

3.  Ex vivo toxicological evaluation of experimental anticancer gold(i) complexes with lansoprazole-type ligands.

Authors:  Natalia Estrada-Ortiz; Elena Lopez-Gonzales; Ben Woods; Stefan Stürup; Inge A M de Graaf; Geny M M Groothuis; Angela Casini
Journal:  Toxicol Res (Camb)       Date:  2019-09-20       Impact factor: 3.524

4.  Protein metalation by metal-based drugs: reactions of cytotoxic gold compounds with cytochrome c and lysozyme.

Authors:  Chiara Gabbiani; Lara Massai; Federica Scaletti; Elena Michelucci; Laura Maiore; Maria Agostina Cinellu; Luigi Messori
Journal:  J Biol Inorg Chem       Date:  2012-11-07       Impact factor: 3.358

5.  Nucleus-Targeted Organoiridium-Albumin Conjugate for Photodynamic Cancer Therapy.

Authors:  Pingyu Zhang; Huaiyi Huang; Samya Banerjee; Guy J Clarkson; Chen Ge; Cinzia Imberti; Peter J Sadler
Journal:  Angew Chem Int Ed Engl       Date:  2019-01-21       Impact factor: 15.336

Review 6.  Metal- and Semimetal-Containing Inhibitors of Thioredoxin Reductase as Anticancer Agents.

Authors:  Valentina Gandin; Aristi P Fernandes
Journal:  Molecules       Date:  2015-07-14       Impact factor: 4.411

7.  Repurposing Auranofin and Evaluation of a New Gold(I) Compound for the Search of Treatment of Human and Cattle Parasitic Diseases: From Protozoa to Helminth Infections.

Authors:  Liwen Feng; Sébastien Pomel; Perle Latre de Late; Alexandre Taravaud; Philippe M Loiseau; Louis Maes; Fidelis Cho-Ngwa; Christina A Bulman; Chelsea Fischer; Judy A Sakanari; Peter D Ziniel; David L Williams; Elisabeth Davioud-Charvet
Journal:  Molecules       Date:  2020-11-01       Impact factor: 4.411

8.  Dual targeting of the cancer antioxidant network with 1,4-naphthoquinone fused Gold(i) N-heterocyclic carbene complexes.

Authors:  R McCall; M Miles; P Lascuna; B Burney; Z Patel; K J Sidoran; V Sittaramane; J Kocerha; D A Grossie; J L Sessler; K Arumugam; J F Arambula
Journal:  Chem Sci       Date:  2017-07-21       Impact factor: 9.825

9.  Mechanistic Insights Into the Anticancer Properties of the Auranofin Analog Au(PEt3)I: A Theoretical and Experimental Study.

Authors:  Iogann Tolbatov; Damiano Cirri; Lorella Marchetti; Alessandro Marrone; Cecilia Coletti; Nazzareno Re; Diego La Mendola; Luigi Messori; Tiziano Marzo; Chiara Gabbiani; Alessandro Pratesi
Journal:  Front Chem       Date:  2020-09-18       Impact factor: 5.221

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.